VDI
RMD icon

Vaughan David Investments’s ResMed RMD Stock Holding History

Vaughan David Investments’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.2M Buy
216,332
+6,647
+3% +$1.38M 0.84% 57
2026
Q1 		$47.1M Buy
209,685
+4,754
+2% +$1.18M 1% 45
2025
Q4 		$49.4M Buy
204,931
+794
+0.4% +$203K 1.07% 37
2025
Q3 		$55.9M Sell
204,137
-4,092
-2% -$1.12M 1.21% 24
2025
Q2 		$53.7M Buy
208,229
+32
+0% +$7.63K 1.2% 24
2025
Q1 		$46.6M Buy
208,197
+1,975
+1% +$461K 1.09% 43
2024
Q4 		$47.2M Buy
206,222
+2,158
+1% +$520K 1.12% 32
2024
Q3 		$49.8M Buy
204,064
+6,155
+3% +$1.38M 1.15% 29
2024
Q2 		$37.9M Buy
197,909
+6,440
+3% +$1.31M 0.96% 52
2024
Q1 		$37.9M Buy
191,469
+21,010
+12% +$3.85M 0.94% 53
2023
Q4 		$29.3M Buy
+170,459
New +$26.2M 0.8% 75

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vaughan David Investments's RMD Position: Q2 2026 in Review

Vaughan David Investments increased its ResMed (RMD) stake by 3.2% in Q2 2026, buying an estimated $1.38M and bringing the position to 216,332 shares worth $42.2M. The position accounts for 0.84% of the portfolio, ranked #57.

Vaughan David Investments first reported a position in RMD in Q4 2023 and has held it in 11 quarters since. The position peaked at $55.9M in Q3 2025. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Vaughan David Investments held 216,332 shares of ResMed worth $42.2M as of Q2 2026.
  • Vaughan David Investments bought 6,647 ResMed shares in Q2 2026, an estimated $1.38M.
  • ResMed made up 0.84% of Vaughan David Investments's portfolio in Q2 2026, its #57 holding.
  • Vaughan David Investments first reported a position in ResMed in Q4 2023 and has held it in 11 quarters since.
  • Vaughan David Investments's ResMed position peaked at $55.9M in Q3 2025.
  • 880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Vaughan David Investments's 13F filing for Q2 2026, filed 11 Aug 2026.